Japan Medical Dynamic Marketing, INC. (7600.T)
JPY 551.0
(-1.43%)
JPY 551.0
(-1.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.74 Billion JPY | -13.72% |
| 2022 | 2.02 Billion JPY | -23.93% |
| 2021 | 2.66 Billion JPY | 22.71% |
| 2020 | 2.16 Billion JPY | -17.98% |
| 2019 | 2.64 Billion JPY | 18.33% |
| 2018 | 2.23 Billion JPY | 9.27% |
| 2017 | 2.04 Billion JPY | 7.09% |
| 2016 | 1.9 Billion JPY | 11.83% |
| 2015 | 1.7 Billion JPY | 31.83% |
| 2014 | 1.29 Billion JPY | 95.87% |
| 2013 | 661.35 Million JPY | 533.79% |
| 2012 | -152.45 Million JPY | 0.0% |
| 2011 | - JPY | -100.0% |
| 2010 | 536.07 Million JPY | -34.5% |
| 2009 | 818.49 Million JPY | 132.6% |
| 2008 | 351.88 Million JPY | -61.58% |
| 2007 | 915.81 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 366.28 Million JPY | -34.97% |
| 2024 Q2 | 302.95 Million JPY | -17.29% |
| 2023 Q4 | 563.26 Million JPY | -0.46% |
| 2023 FY | 1.74 Billion JPY | -13.72% |
| 2023 Q1 | 346.38 Million JPY | -32.6% |
| 2023 Q2 | 271.4 Million JPY | -21.65% |
| 2023 Q3 | 565.85 Million JPY | 108.49% |
| 2022 Q3 | 583.73 Million JPY | 36.26% |
| 2022 Q4 | 513.89 Million JPY | -11.96% |
| 2022 Q1 | 498.65 Million JPY | -25.55% |
| 2022 Q2 | 428.39 Million JPY | -14.09% |
| 2022 FY | 2.02 Billion JPY | -23.93% |
| 2021 Q3 | 933.54 Million JPY | 85.32% |
| 2021 Q4 | 669.77 Million JPY | -28.25% |
| 2021 Q1 | 554.44 Million JPY | -7.47% |
| 2021 Q2 | 503.75 Million JPY | -9.14% |
| 2021 FY | 2.66 Billion JPY | 22.71% |
| 2020 Q2 | 581.7 Million JPY | 140.21% |
| 2020 Q4 | 599.21 Million JPY | -19.66% |
| 2020 FY | 2.16 Billion JPY | -17.98% |
| 2020 Q1 | 242.15 Million JPY | -59.32% |
| 2020 Q3 | 745.87 Million JPY | 28.22% |
| 2019 Q3 | 782.83 Million JPY | 26.25% |
| 2019 Q4 | 595.23 Million JPY | -23.96% |
| 2019 FY | 2.64 Billion JPY | 18.33% |
| 2019 Q1 | 646.38 Million JPY | 4.04% |
| 2019 Q2 | 620.08 Million JPY | -4.07% |
| 2018 Q2 | 401.13 Million JPY | -12.44% |
| 2018 FY | 2.23 Billion JPY | 9.27% |
| 2018 Q4 | 621.29 Million JPY | -17.65% |
| 2018 Q3 | 754.42 Million JPY | 88.07% |
| 2018 Q1 | 458.11 Million JPY | -13.27% |
| 2017 Q1 | 459.61 Million JPY | 5.14% |
| 2017 Q3 | 703.12 Million JPY | 98.4% |
| 2017 Q4 | 528.2 Million JPY | -24.88% |
| 2017 Q2 | 354.4 Million JPY | -22.89% |
| 2017 FY | 2.04 Billion JPY | 7.09% |
| 2016 Q4 | 437.12 Million JPY | -28.54% |
| 2016 Q2 | 519.56 Million JPY | 52.13% |
| 2016 Q1 | 341.52 Million JPY | -30.44% |
| 2016 Q3 | 611.67 Million JPY | 17.73% |
| 2016 FY | 1.9 Billion JPY | 11.83% |
| 2015 Q4 | 490.97 Million JPY | -6.46% |
| 2015 FY | 1.7 Billion JPY | 31.83% |
| 2015 Q2 | 362.04 Million JPY | 9.75% |
| 2015 Q1 | 329.87 Million JPY | 24.33% |
| 2015 Q3 | 524.88 Million JPY | 44.98% |
| 2014 Q3 | 537.59 Million JPY | 112.54% |
| 2014 Q1 | 239.56 Million JPY | -31.83% |
| 2014 FY | 1.29 Billion JPY | 95.87% |
| 2014 Q4 | 265.31 Million JPY | -50.65% |
| 2014 Q2 | 252.94 Million JPY | 5.58% |
| 2013 Q2 | 70.59 Million JPY | 353.84% |
| 2013 FY | 661.35 Million JPY | 533.79% |
| 2013 Q4 | 351.42 Million JPY | 31.55% |
| 2013 Q3 | 267.14 Million JPY | 278.44% |
| 2013 Q1 | -27.8 Million JPY | -131.96% |
| 2012 Q1 | -51.78 Million JPY | 0.0% |
| 2012 Q2 | -177.38 Million JPY | -242.56% |
| 2012 Q3 | -10.3 Million JPY | 94.19% |
| 2012 Q4 | 87 Million JPY | 944.41% |
| 2012 FY | -152.45 Million JPY | 0.0% |
| 2011 Q3 | 162.38 Million JPY | 825.97% |
| 2011 Q2 | 17.53 Million JPY | -85.09% |
| 2011 Q1 | 117.62 Million JPY | -40.16% |
| 2011 FY | - JPY | -100.0% |
| 2010 FY | 536.07 Million JPY | -34.5% |
| 2010 Q3 | 178.87 Million JPY | 316.01% |
| 2010 Q4 | 196.57 Million JPY | 9.9% |
| 2010 Q2 | 42.99 Million JPY | -21.48% |
| 2010 Q1 | 54.75 Million JPY | -84.87% |
| 2009 Q2 | 76.61 Million JPY | 1168.03% |
| 2009 Q1 | -7.17 Million JPY | -102.58% |
| 2009 Q4 | 361.84 Million JPY | 11.24% |
| 2009 FY | 818.49 Million JPY | 132.6% |
| 2009 Q3 | 325.28 Million JPY | 324.59% |
| 2008 FY | 351.88 Million JPY | -61.58% |
| 2008 Q3 | 130.35 Million JPY | 0.0% |
| 2008 Q4 | 277.51 Million JPY | 112.9% |
| 2007 FY | 915.81 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DVx Inc. | 653.15 Million JPY | -167.459% |
| Seikagaku Corporation | 433 Million JPY | -303.444% |
| Eiken Chemical Co., Ltd. | 3.37 Billion JPY | 48.27% |
| Create Medic Co., Ltd. | 803.24 Million JPY | -117.482% |
| PHC Holdings Corporation | 8.31 Billion JPY | 78.983% |
| Techno Medica Co., Ltd. | 1.84 Billion JPY | 5.071% |
| Rion Co., Ltd. | 3.47 Billion JPY | 49.728% |
| Nihon Kohden Corporation | 19.59 Billion JPY | 91.084% |
| Fukuda Denshi Co., Ltd. | 26.5 Billion JPY | 93.409% |
| Japan Lifeline Co., Ltd. | 10.89 Billion JPY | 83.961% |
| 3-D Matrix, Ltd. | -2.11 Billion JPY | 182.517% |
| CYBERDYNE Inc. | -1.73 Billion JPY | 200.629% |